Next Article in Journal
Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial
Previous Article in Journal
Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg?
 
 
Article

Article Versions Notes

J. Clin. Med. 2024, 13(17), 5238; https://doi.org/10.3390/jcm13175238
Action Date Notes Link
article xml file uploaded 4 September 2024 12:18 CEST Original file -
article xml uploaded. 4 September 2024 12:18 CEST Update https://www.mdpi.com/2077-0383/13/17/5238/xml
article pdf uploaded. 4 September 2024 12:18 CEST Version of Record https://www.mdpi.com/2077-0383/13/17/5238/pdf
article html file updated 4 September 2024 12:21 CEST Original file https://www.mdpi.com/2077-0383/13/17/5238/html
Back to TopTop